References
- Barton , S.E. , Englehard , P. and Conant , M. 2006 . Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: A review of the clinical studies . International Journal of STD & AIDS , 17 : 429 – 435 .
- Collins , E. , Wagner , M.D. and Walmsley , S. 2000 . Psychosocial impact of the lipodystrophy syndrome in HIV infection . AIDS Reader , 10 : 546 – 550 .
- Echavez , M. , and Horstman , W. 2005 . Relationship between lipoatrophy and quality of life . AIDS Reader , July , 369 – 375 .
- Moyle , G.J. , Brown , S. , Lysakova , L. and Barton , S.E. 2006 . Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy . HIV Medicine , 7 : 181 – 185 .
- Power , R. , Tate , H.L. , McGill , S.M. and Taylor , C. 2003 . A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals . Sexually Transmitted Infections , 79 : 137 – 141 .
- Vleggaar , D. 2006 . Poly-L-lactic acid: Consultation on the injection techniques . Journal of the European Academy of Dermatology and Venereology , 20 ( Suppl. 1 ) : 17 – 21 .
- Zigmond , A.S. and Snath , R.P. 1983 . The hospital anxiety and depression scale . Acta Psychiatrica Scandinavia , 67 : 361 – 370 .